000 | 01913 a2200517 4500 | ||
---|---|---|---|
005 | 20250513230416.0 | ||
264 | 0 | _c20010308 | |
008 | 200103s 0 0 eng d | ||
022 | _a1040-0605 | ||
024 | 7 |
_a10.1152/ajplung.2001.280.2.L258 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBlumberg, F C | |
245 | 0 | 0 |
_aThe NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Lung cellular and molecular physiology _cFeb 2001 |
||
300 |
_aL258-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEndothelin-1 _xgenetics |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlyceraldehyde-3-Phosphate Dehydrogenases _xgenetics |
650 | 0 | 4 | _aHematocrit |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 |
_aHypoxia _xdrug therapy |
650 | 0 | 4 |
_aLung _xblood supply |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMolsidomine _xadministration & dosage |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aWolf, K | |
700 | 1 | _aSandner, P | |
700 | 1 | _aLorenz, C | |
700 | 1 | _aRiegger, G A | |
700 | 1 | _aPfeifer, M | |
773 | 0 |
_tAmerican journal of physiology. Lung cellular and molecular physiology _gvol. 280 _gno. 2 _gp. L258-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajplung.2001.280.2.L258 _zAvailable from publisher's website |
999 |
_c11098560 _d11098560 |